Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 9699
Country/Region: Cambodia
Year: 2009
Main Partner: National Center for HIV/AIDS, Dermatology and STDs - Cambodia
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $339,000

Funding for Treatment: Adult Treatment (HTXS): $277,000

THIS IS AN ONGOING ACTIVITY.

The purpose of the National Center for HIV/AIDS, Dermatology and STDs (NCHADS) Cooperative

Agreement is to promote ongoing collaborative between NCHADS and HHS/CDC in response to the HIV

epidemic. Key focus areas of the NCHADS Cooperative Agreement include improving prevention of mother

to child transmission (PMTCT) coverage, improving the Continuum of Care (CoC) for persons living with

HIV/AIDS (in particular those with co-existing TB disease) and improving the collection and use of data to

inform HIV program activities.

ACTIVITY HAS BEEN MODIFIED IN THE FOLLOWING WAYS:

This activity has been modified from that described in the COP 08 Activity Narrative to conform with the

evolving quality improvement program of NCHADS. The quality improvement plan outlined in COP 08 has

been modified with a plan in which mentoring in quality improvement would be performed by an NCHADS

quality improvement team consisting of representatives from its Research Unit, Data Management Unit, and

AIDS Care Unit, with assistance from technical advisors from donor partners including HHS/CDC and USG

partners. As operational districts (ODs) with developed CoC scale up their data entry and data management

capacity, they will be able to generate report cards on performance on a number of quality indicators that

have been developed over the past year with the input of USG technical advisors. In FY 09, a limited

number of operational districts will be selected to pilot quality improvement interventions. Site visits by the

NCHADS Quality Improvement team will be conducted to review performance achievements of the

operational district, identify areas of weakness, and assist the operational district in developing plans to

address these weaknesses. Follow-up site visits will be planned to assess steps taken to address the

identified weaknesses and to review subsequent quality measures.

In COP 09, USG will support these quality improvement activities in two operational districts of Banteay

Meanchey Province. In addition, HHS/CDC will fund data management /data entry personnel at the

Banteay Meanchey Provincial AIDS Office who will be charged with maintaining a timely and accurate

database so that meaningful and timely quality improvement indicators can be determined. The HHS/CDC

Clinical Advisor and Deputy Director will serve as a member of the quality improvement team mentoring

these operational districts. It is expected that procedures adopted in these early efforts to assure and

improve quality will inform future, more widespread continuous quality improvement (CQI) activities.

In COP 09, HHS/CDC will continue to provide support to four OI/ART sites in three Operational Districts of

Banteay Meanchey Province. This support will include funding for participation of staff in regional network

meetings and national meetings organized by NCHADS, as well as funds to support transportation of

indigent patients to regularly scheduled visits to the OI/ART clinic.

In addition to the above activities, NCHADS will continue to strengthen ARV services in Banteay Meanchey,

Battambang, and Pursat Provinces and the municipality of Pailin by sponsoring two regional network

meetings for clinicians and counselors, refresher clinical training, courses on OI/ART, refresher training for

nurse counselors, and management training workshops for leadership at the provincial and OD levels. In

addition, they will be providing funds for three providers from each province and Pailin municipality to attend

an appropriate regional conference.

New/Continuing Activity: Continuing Activity

Continuing Activity: 18456

Continued Associated Activity Information

Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds

System ID System ID

18456 11308.08 HHS/Centers for National Center for 7344 7344.08 NCHADS CoAg $96,195

Disease Control & HIV/AIDS GHAI

Prevention Dermatology and

STDs

11308 11308.07 HHS/Centers for National Center for 5755 5755.07 NCHADS CoAg $37,700

Disease Control & HIV/AIDS GHAI

Prevention Dermatology and

STDs

Table 3.3.09:

Funding for Laboratory Infrastructure (HLAB): $62,000

THIS IS AN ONGOING ACTIVITY.

The purpose of the National Center for HIV/AIDS Dermatology and STDs (NCHADS) Cooperative

Agreement is to promote ongoing collaboration between NCHADS and HHS/CDC in response to the HIV

epidemic. Key focus areas of the NCHADS Cooperative Agreement include improving prevention of mother

to child transmission (PMTCT) coverage, improving the Continuum of Care (CoC) for persons living with

HIV/AIDS (in particular those with co-existing TB disease) and improving the collection and use of data to

inform HIV program activities.

This initiative includes ongoing support of laboratory activities. The HHS/CDC cooperative agreement with

NCHADS will continue to partially support an integrated laboratories initiative, and provide support to

laboratories in four USG focus areas: the three provinces of Banteay Meanchey, Battambang, Pursat, and

the municipality of Pailin. ARV services are provided at 10 sites in these provinces and laboratory services

must be available to clinically monitor the care and treatment of HIV patients.

On-site technical assistance, including review of laboratory methods, standard operating procedures, and

quality assurance, will be provided by the HHS/CDC laboratory analyst stationed in Battambang.

Workshops on laboratory techniques and quality assurance will be conducted in collaboration with the

National Institute of Public Health (NIPH) laboratory. USG funds will be used to support laboratory

equipment maintenance agreements and purchase quality control reagents, as necessary. In addition,

USG funds will be used to purchase laboratory equipment for laboratories in USG focus provinces where

ARV services are provided. Additionally, this initiative will support the phase 2 evaluations of HIV test kits in

order to review the HIV testing algorithm in country.

New/Continuing Activity: Continuing Activity

Continuing Activity: 18452

Continued Associated Activity Information

Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds

System ID System ID

18452 18452.08 HHS/Centers for National Center for 7461 7461.08 NCHADS CoAg $427,930

Disease Control & HIV/AIDS Base

Prevention Dermatology and

STDs

Table 3.3.16: